Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Keya Medical Technology Co. Ltd. has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This action is assigned to 1 distinct examiner, reflecting a concentrated prosecution state. The review takes place within a distinct art unit, which limits the scope of current interactions with the patent office.
The busiest examiner, NEGIN, RUSSELL SCOTT, is responsible for the pending office action. Because there is a distinct examiner and a distinct art unit involved, the current portfolio activity is entirely centralized under a particular point of review. This lack of distribution means that the outcome of the pending matter depends on the interaction with NEGIN, RUSSELL SCOTT.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| NEGIN, RUSSELL SCOTT | 1 | 55.9% | +34.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17971038 | METHOD AND SYSTEM FOR ANATOMICAL TREE STRUCTURE ANALYSIS | NEGIN, RUSSELL SCOTT | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17971038 | METHOD AND SYSTEM FOR ANATOMICAL TREE STRUCTURE ANALYSIS | NEGIN, RUSSELL SCOTT | — |
| Art Unit | Apps |
|---|---|
| 1686 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17971038 | METHOD AND SYSTEM FOR ANATOMICAL TREE STRUCTURE ANALYSIS | NEGIN, RUSSELL SCOTT | 1686 | §103§112 | Non-Final OA | — | Pending | Oct 21, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialKeya Medical Technology Co. Ltd. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Russell Scott Negin has the most, with 1 of Keya Medical Technology Co. Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
